News Related to MiniMed Flex

Related coverage linked through entity extraction aliases.

MiniMed Completes $538M IPO as Medtronic Diabetes Separation Advances

Jun 13, 2026

MiniMed completed its $538 million IPO as its separation from Medtronic advances, with shares trading on the Nasdaq. Medtronic submitted the next-generation MiniMed Flex insulin pump to the FDA and reported a 14.8% year-over-year revenue increase for its Diabetes business. The full separation is expected to be complete by the end of calendar year 2026.

FDA actions advance MiniMed and Portal Diabetes insulin pump systems

Apr 14, 2026

The FDA cleared MiniMed Flex, a screen-free insulin pump controlled by smartphone, and granted breakthrough device designation to Portal Diabetes’ implantable Portal Pump system. Portal Diabetes also began a Phase I study of Portal Insulin, while MiniMed said Flex supports its latest algorithm, sensors and infusion sets.